Journal of Peking University (Health Sciences) ›› 2026, Vol. 58 ›› Issue (4): 716-722. doi: 10.19723/j.issn.1671-167X.2026.04.006

Previous Articles     Next Articles

Preliminary clinical experience of domestic robot-assisted laparoscopic radical nephrectomy with venous tumor thrombectomy

Zhuo LIU, Shuai LIU, Guoliang WANG, Xiaojun TIAN, Hongxian Zhang, Lei LIU, Lulin MA*(), Shudong ZHANG*()   

  1. Department of Urology, Peking University Third Hospital, Beijing 100191, China
  • Received:2026-02-27 Online:2026-08-18 Published:2026-05-15
  • Contact: Lulin MA, Shudong ZHANG
  • Supported by:
    the National Natural Science Foundation of China(82473287); the Peking University Third Hospital Clinical Cohort Construction Project(BYSYDL2025031)

RICH HTML

  

Abstract:

Objective: To preliminarily investigate the safety and feasibility of domestic Jingfeng MP1000 multi-port robotic surgical system-assisted laparoscopic radical nephrectomy with venous tumor thrombectomy. Methods: Clinical data of 15 patients with renal cell carcinoma (RCC) and venous tumor thrombus who underwent Jingfeng MP1000 robot-assisted laparoscopic radical nephrectomy with venous tumor thrombectomy at the Department of Urology, Peking University Third Hospital from June 2024 to January 2026 were retrospectively analyzed. The primary outcomes were the success rate of the robotic procedure, overall complication rate, and major complication rate (Clavien-Dindo ≥ grade Ⅲ). Secondary outcomes included operative time, estimated blood loss, and length of hospital stay. Baseline characteristics, perioperative outcomes, pathological results, and postoperative complications were collected and analyzed using descriptive statistical methods. Results: All the 15 procedures were successfully completed with robotic assistance, with no conversions to open surgery. The success rate of robotic-assisted surgery was 100%. The median patient age was 60 years, and the median body mass index was 25.6 kg/m2. Ten patients had right-sided and 5 had left-sided tumors, with a median tumor diameter of 9.1 cm. According to the Mayo classification, there were 5 cases of grade 0, 4 of grade Ⅰ, 5 of grade Ⅱ, and 1 of grade Ⅲ thrombus. The median operative time was 233.0 min, the median estimated blood loss was 250.0 mL, and 5 patients (33.3%) received blood transfusions. The median postoperative hospital stay was 6 days. Only one patient (6.7%) experienced a Clavien-Dindo grade Ⅱ complication (lymphatic leakage), with no grade ≥Ⅲ severe complications or perioperative mortality. Postoperative pathology revealed clear cell renal cell carcinoma in 12 cases, and venous wall invasion was confirmed in 8 patients (53.3%). After a median follow-up of 4.4 months, one patient developed duodenal metastasis 10 months postoperatively. Conclusion: The domestic Jingfeng MP1000 multi-port robotic system-assisted laparoscopic radical nephrectomy with venous tumor thrombectomy is technically safe and feasible, with favorable perioperative outcomes and a low complication rate. Its long-term oncological efficacy requires further validation through large-scale, prospective studies.

Key words: Kidney neoplasms, Venous tumor thrombus, Robotic-assisted surgery, Radical nephrectomy

CLC Number: 

  • R737.11

Table 1

Clinical characteristics of patients with renal cell carcinoma and venous tumor thrombus"

Feature Jingfeng group (n=15) Da Vinci group (n=227) P value
Age/years 60 (53, 71) 60 (52, 67) 0.482
Male 10 (66.7) 154 (67.8) >0.999
BMI/(kg/m2) 25.6 (24.1, 26.8) 24.2 (22.0, 27.0) 0.085
Side 0.963
    Left 5 (33.3) 78 (34.4)
    Right 10 (66.7) 148 (65.2)
    Bilateral 0 (0) 1 (0.4)
Size/cm 9.1 (7.6, 10.6) 8.7 (6.7, 10.7) 0.613
Mayo classification 0.234
    0 5 (33.3) 46 (20.3)
    Ⅰ 4 (26.7) 27 (11.9)
    Ⅱ 5 (33.3) 122 (53.7)
    Ⅲ 1 (6.7) 19 (8.4)
    Ⅳ 0 (0) 13 (5.7)
ASA 0.834
    Ⅰ 0 (0) 9 (4.0)
    Ⅱ 11 (73.3) 169 (74.4)
    Ⅲ 4 (26.7) 48 (21.1)
    Ⅳ 0 (0) 1 (0.4)
Operative time/min 233.0 (128.0, 274.0) 224.0 (163.5, 303.5) 0.582
Estimated blood loss/mL 250.0 (100.0, 575.0) 400.0 (200.0, 1 000.0) 0.084
Patients receiving transfusion 5 (33.3) 107 (47.1) 0.424
Lymph node dissection 9 (60.0) 140 (61.7) >0.999
Adrenalectomy 11 (73.3) 127 (55.9) 0.282
Postoperative hospital stay/d 6 (5, 8) 7 (5, 9) 0.369
Preoperative Scr/(μmol/L) 100.0 (90.5, 116.0) 93.0 (75.5, 109.0) 0.190
Postoperative Scr/(μmol/L) 103.0 (90.0, 121.0) 104.0 (85.8, 133.0) 0.749
Venous tumor thrombus combined with bland thrombus 1 (6.7) 33 (14.5) 0.702
Histological type 0.890
    Clear cell RCC 12 (80.0) 178 (78.4)
    Papillary RCC 1 (6.7) 11 (4.8)
    TFE3-rearranged RCC 0 (0) 8 (3.5)
    TFEB-altered RCC 0 (0) 2 (0.9)
    Fumarate hydratase-deficient RCC 0 (0) 8 (3.5)
    Unclassified RCC 2 (13.3) 16 (7.0)
    Indeterminate histology due to treatment response 0 (0) 4 (1.8)
Four-tiered WHO/ISUP grading system 0.752
    Ⅰ 0 (0) 1 (0.4)
    Ⅱ 5 (33.3) 43 (18.9)
    Ⅲ 6 (40.0) 104 (45.8)
    Ⅳ 3 (20.0) 59 (26.0)
    Not graded 1 (6.7) 20 (8.8)
T stage 0.762
    T3a 4 (26.7) 45 (19.8)
    T3b 3 (20.0) 61 (26.9)
    T3c 6 (40.0) 103 (45.4)
    T4 2 (13.3) 18 (7.9)
M1 5 (33.3) 73 (32.2) >0.999
Invade the wall of the vena cava 8 (53.3) 140 (61.7) 0.589
Complication 1 (6.7) 57 (25.1) 0.128
1
Siegel RL , Giaquinto AN , Jemal A . Cancer statistics, 2024[J]. CA A Cancer J Clin, 2024, 74 (1): 12- 49.
2
Garg H , Psutka SP , Hakimi AA , et al. A decade of robotic-assisted radical nephrectomy with inferior vena cava thrombectomy: A systematic review and meta-analysis of perioperative outcomes[J]. J Urol, 2022, 208 (3): 542- 560.

doi: 10.1097/JU.0000000000002829
3
Psutka SP , Leibovich BC . Management of inferior vena cava tumor thrombus in locally advanced renal cell carcinoma[J]. Ther Adv Urol, 2015, 7 (4): 216- 229.

doi: 10.1177/1756287215576443
4
Pyrgidis N , Schulz GB , Stief CG , et al. Perioperative outcomes after radical nephrectomy with inferior vena cava thrombectomy[J]. Cancers, 2025, 17 (7): 1083.

doi: 10.3390/cancers17071083
5
Vuong NS , Ferriere JM , Michiels C , et al. Robot-assisted versus open surgery for radical nephrectomy with level 1-2 vena cava tumor thrombectomy: A French monocenter experience (UroCCR study #73)[J]. Minerva Urol Nephrol, 2021, 73 (4): 498- 508.
6
Campi R , Tellini R , Sessa F , et al. Techniques and outcomes of minimally-invasive surgery for nonmetastatic renal cell carcinoma with inferior vena cava thrombosis: A systematic review of the literature[J]. Minerva Urol Nefrol, 2019, 71 (4): 339- 358.
7
张树栋, 谢睿扬. 机器人手术时代的肾癌合并腔静脉瘤栓治疗策略[J]. 北京大学学报(医学版), 2024, 56 (4): 562- 564.

doi: 10.19723/j.issn.1671-167X.2024.04.002
8
Wang B , Huang Q , Liu K , et al. Robot-assisted level Ⅲ-Ⅳ inferior vena cava thrombectomy: Initial series with step-by-step procedures and 1-yr outcomes[J]. Eur Urol, 2020, 78 (1): 77- 86.

doi: 10.1016/j.eururo.2019.04.019
9
Shah MS , Wang KR , Shah YB , et al. A narrative review on robotic surgery as treatment for renal cell carcinoma with inferior vena cava thrombus[J]. J Clin Med, 2024, 13 (5): 1308.

doi: 10.3390/jcm13051308
10
Bosscha SRJ , Amiri R , Jamaludin F , et al. Cost analyses in randomized trials on robot-assisted surgery: Systematic review[J]. BJS Open, 2025, 10 (1): zraf161.

doi: 10.1093/bjsopen/zraf161
11
刘世豪, 徐丽清, 李新飞, 等. 国产模块化手术机器人系统辅助肾盂成形术的可行性和安全性评价[J]. 北京大学学报(医学版), 2025, 57 (4): 779- 783.

doi: 10.19723/j.issn.1671-167X.2025.04.024
12
陈劲果, 王之仕, 朱礼乐, 等. 国产手术机器人在泌尿外科中的应用与展望[J]. 机器人外科学杂志(中英文), 2025, 6 (6): 916- 921.
13
Wang B , Gao W , Yang K , et al. Robot-assisted upper urinary tract repair surgery using the MP1000 system: A prospective, single-center, single-arm clinical study[J]. Transl Androl Urol, 2025, 14 (6): 1723- 1733.

doi: 10.21037/tau-2025-228
14
Hanaoka M , Hino H , Shiomi A , et al. The Eastern Cooperative Oncology Group Performance Status as a prognostic factor of stage Ⅰ-Ⅲ colorectal cancer surgery for elderly patients: A multi-institutional retrospective analysis[J]. Surg Today, 2022, 52 (7): 1081- 1089.

doi: 10.1007/s00595-021-02412-4
15
Shen D , Wang H , Wang C , et al. Cumulative sum analysis of the operator learning curve for robot-assisted mayo clinic level Ⅰ-Ⅳ inferior vena cava thrombectomy associated with renal carcinoma: A study of 120 cases at a single center[J]. Med Sci Monit, 2020, 26, e922987.
16
Trpkov K , Hes O , Williamson SR , et al. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia[J]. Mod Pathol, 2021, 34 (7): 1392- 1424.

doi: 10.1038/s41379-021-00779-w
17
Dindo D , Demartines N , Clavien PA . Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey[J]. Ann Surg, 2004, 240 (2): 205- 213.

doi: 10.1097/01.sla.0000133083.54934.ae
18
Liu Z , Hong P , Zhu G , et al. Pure retroperitoneal laparoscopic radical nephrectomy and thrombectomy with delayed occlusion of the proximal inferior vena cava (DOPI) technique for renal tumor with level Ⅱ-Ⅲ venous tumor thrombus[J]. BMC Cancer, 2021, 21 (1): 627.

doi: 10.1186/s12885-021-08392-5
19
刘帅, 刘茁, 管允鹤, 等. 机器人辅助腹腔镜下腔静脉节段性切除术治疗肾肿瘤瘤栓侵犯血管壁[J]. 北京大学学报(医学版), 2025, 57 (4): 796- 802.

doi: 10.19723/j.issn.1671-167X.2025.04.027
20
Bang S , Hong SH . Robot-assisted radical nephrectomy with inferior vena cava thrombectomy: A narrative review with step-by-step procedures[J]. J Urol Oncol, 2024, 22 (2): 105- 114.

doi: 10.22465/juo.244800420021
21
Essandoh M , Tang J , Essandoh G , et al. Transesophageal echocardiography guidance for robot-assisted level Ⅲ inferior vena cava tumor thrombectomy: A novel approach to intraoperative care[J]. J Cardiothorac Vasc Anesth, 2018, 32 (6): 2623- 2627.

doi: 10.1053/j.jvca.2018.05.017
22
Wang B , Li H , Ma X , et al. Robot-assisted laparoscopic inferior vena cava thrombectomy: Different sides require different techniques[J]. Eur Urol, 2016, 69 (6): 1112- 1119.

doi: 10.1016/j.eururo.2015.12.001
23
黄庆波, 彭程, 马鑫, 等. 机器人辅助腹腔镜Mayo Ⅲ~Ⅳ级下腔静脉癌栓取出术的经验总结(附5例报告)[J]. 中华泌尿外科杂志, 2019, 40 (2): 81- 85.
24
Abaza R , Shabsigh A , Castle E , et al. Multi-institutional expe-rience with robotic nephrectomy with inferior vena cava tumor thrombectomy[J]. J Urol, 2016, 195 (4 Pt 1): 865- 871.
25
Miranda M , Polido J , Fernandes M , et al. Renal cell carcinoma with inferior vena cava thrombus: Survival and prognostic factors in surgically treated patients[J]. Urol Ann, 2024, 16 (4): 277- 283.

doi: 10.4103/ua.ua_113_23
[1] Boda GUO, Min LU, Guoliang WANG, Hongxian ZHANG, Lei LIU, Xiaofei HOU, Lei ZHAO, Xiaojun TIAN, Shudong ZHANG. Clinicopathological and prognostic differences between clear cell and non-clear cell renal cell carcinoma with venous tumor thrombus [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 644-649.
[2] Zhanyi ZHANG, Min LU, Yuehao SUN, Jinghan DONG, Xiaofei HOU, Chunlei XIAO, Guoliang WANG, Xiaojun TIAN, Lulin MA, Hongxian ZHANG, Shudong ZHANG. Clinicopathological features and survival analysis of TFE3-rearranged renal cell carcinoma with venous tumor thrombus [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 650-661.
[3] Zezhen ZHOU, Liyuan GE, Fan ZHANG, Shaohui DENG, Ye YAN, Hongxian ZHANG, Guoliang WANG, Lei LIU, Yi HUANG, Shudong ZHANG. A retrospective matching study of partial nephrectomy and radical nephrectomy for pathological T3a stage renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 704-710.
[4] Shuai LIU, Zhuo LIU, Yunhe GUAN, Guoliang WANG, Xiaojun TIAN, Hongxian ZHANG, Lei LIU, Lulin MA, Shudong ZHANG. Robot-assisted laparoscopic inferior vena cava segmental resection for renal tumor with tumor thrombus invading the vascular wall [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 796-802.
[5] Binshuai WANG,Min QIU,Qianjin ZHANG,Maofeng TIAN,Lei LIU,Guoliang WANG,Min LU,Xiaojun TIAN,Shudong ZHANG. Experience in diagnosis and treatment of 6 cases of renal Ewing's sarcoma with venous thrombus [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 636-639.
[6] Zi-xuan XUE,Shi-ying TANG,Min QIU,Cheng LIU,Xiao-jun TIAN,Min LU,Jing-han DONG,Lu-lin MA,Shu-dong ZHANG. Clinicopathologic features and prognosis of young renal tumors with tumor thrombus [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 802-811.
[7] Dong LAN,Zhuo LIU,Yu-xuan LI,Guo-liang WANG,Xiao-jun TIAN,Lu-lin MA,Shu-dong ZHANG,Hong-xian ZHANG. Risk factors for massive hemorrhage after radical nephrectomy and removal of venous tumor thrombus [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 825-832.
[8] Min QIU,You-long ZONG,Bin-shuai WANG,Bin YANG,Chu-xiao XU,Zheng-hui SUN,Min LU,Lei ZHAO,Jian LU,Cheng LIU,Xiao-jun TIAN,Lu-lin MA. Treatment outcome of laparoscopic partial nephrectomy in patients with renal tumors of moderate to high complexity [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 833-837.
[9] HAN Song-chen,HUANG Zi-xiong,LIU Hui-xin,XU Tao. Renal functional compensation after unilateral radical nephrectomy of renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 680-685.
[10] LI Xin-fei, PENG Yi-ji, YU Xiao-teng, XIONG Sheng-wei, CHENG Si-da, DING Guang-pu, YANG Kun-lin, TANG Qi, MI Yue, WU Jing-yun, ZHANG Peng, XIE Jia-xin, HAO Han, WANG He, QIU Jian-xing, YANG Jian, LI Xue-song, ZHOU Li-qun. Three dimensional nephrometry system for partial nephrectomy: Our initial exploration [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 613-622.
[11] Xiao-jun TIAN,Min QIU,Zhuo LIU,Ruo-tao XIAO,Yi HUANG,Guo-liang WANG,Xiao-fei HOU,Shu-dong ZHANG,Shen-rong ZHUANG,Lu-lin MA. Single-center study of laparoscopic radical nephrectomy with Mayo 0-2 level inferior vena cava thrombectomy [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1053-1056.
[12] HUANG Zi-xiong, ZHANG Xiao-peng, DONG Sen, LIU Shi-jun, YANG Rong-li, ZHOU Yu-shi, MA Wei-guo. Renal mucinous tubular and spindle cell carcinoma combined with multiple bone metastasis: a case report and literature review [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 732-735.
[13] XU Ben, ZHANG Zhe-nan, LUO Cheng, SONG Hai-feng, ZHANG Qian. Comparison of safety and effectiveness between retroperitoneal laparoscopic tumor aspiration and laparoscopic partial nephrectomy in the treatment of renal angiomyolipoma [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 700-704.
[14] YE Jian-fei, MA Lu-lin, ZHAO Lei, WANG Guo-liang. Segmental vena cava resection for the treatment of renal tumor with invading tumor thrombus [J]. Journal of Peking University(Health Sciences), 2018, 50(1): 183-187.
[15] LIU Chang, CUI Li-gang, WANG Hong-lei. Renal Ewing’s sarcoma/primitive neuroectodermal tumor: a case report and literature review [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 919-923.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!